65.15 0.14 (0.22%) | 05-01 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 79.35 | 1-year : | 84.56 |
Resists | First : | 67.93 | Second : | 72.4 |
Pivot price | 63.26 | |||
Supports | First : | 60.72 | Second : | 50.51 |
MAs | MA(5) : | 64.46 | MA(20) : | 64.12 |
MA(100) : | 0 | MA(250) : | 0 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 71.8 | D(3) : | 56.4 |
RSI | RSI(14): 50.5 | |||
52-week | High : | 71.65 | Low : | 60.72 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SOLV ] has closed below upper band by 14.9%. Bollinger Bands are 0% narrower than normal.
If tomorrow: | Open lower | Open higher |
High: | 66.9 - 67.22 | 67.22 - 67.51 |
Low: | 63.48 - 63.84 | 63.84 - 64.18 |
Close: | 64.56 - 65.12 | 65.12 - 65.65 |
Tue, 02 Apr 2024
3M Spinoff Solventum's Stock Moves Lower on First Day of Trading - The Wall Street Journal
Tue, 02 Apr 2024
3M Says Bye To Solventum - Why I Stick To My Bullish Call (NYSE:SOLV) - Seeking Alpha
Mon, 01 Apr 2024
3M Spinoff Solventum Stock Is Down. What Happens Next. - Barron's
Mon, 01 Apr 2024
3M health care spinoff Solventum becomes Minnesota's newest Fortune 500 company - Axios
Mon, 01 Apr 2024
Solventum completes spin off from 3M - Yahoo Finance
Mon, 01 Apr 2024
Solventum Begins Trading on the New York Stock Exchange - PR Newswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NYSE
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 173 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 16.4 % |
Operating Margin | 17.8 % |
Return on Assets (ttm) | 7.6 % |
Return on Equity (ttm) | 11.5 % |
Qtrly Rev. Growth | 1.5 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 47.47 |
EBITDA (p.s.) | 13.02 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 1,920 (M) |
Levered Free Cash Flow | 1,620 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 1.37 |
Price to Cash Flow | 5.86 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |